# Salivary Fluoride Clearance

> **NCT06735235** · PHASE1 · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 27 (actual)

## Conditions studied

- Caries

## Interventions

- **DRUG:** 0 ppm F
- **DRUG:** 250 ppm F as MFP
- **DRUG:** 1100 ppm as MFP
- **DRUG:** 2800 ppm F as MFP

## Key facts

- **NCT ID:** NCT06735235
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-14
- **Primary completion:** 2021-07-29
- **Final completion:** 2021-07-29
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06735235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06735235, "Salivary Fluoride Clearance". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06735235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*